Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 8 | $948,124 |
Sells | 38 | $30,980,274 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
14 Jun 2024 18:07 | RGEN | REPLIGEN CORP | MADAUS MARTIN D | Director | 14 Jun 2024 | Purchase | 915 | 124.54 | 113,954 | D |
14 Jun 2024 18:07 | RGEN | REPLIGEN CORP | MADAUS MARTIN D | Director | 14 Jun 2024 | Purchase | 700 | 125.46 | 87,822 | D |
14 Jun 2024 17:41 | RGEN | REPLIGEN CORP | HUNT ANTHONY | Chief Executive Officer | 14 Jun 2024 | Purchase | 2,000 | 124.08 | 248,160 | D |
14 Jun 2024 17:42 | RGEN | REPLIGEN CORP | BARTHELEMY NICOLAS | Director | 14 Jun 2024 | Purchase | 1,200 | 125.45 | 150,540 | D |
22 May 2024 17:14 | RGEN | REPLIGEN CORP | HUNT ANTHONY | Chief Executive Officer | 21 May 2024 | Sale | 969 | 171.03 | 165,728 | D |
22 May 2024 17:14 | RGEN | REPLIGEN CORP | HUNT ANTHONY | Chief Executive Officer | 21 May 2024 | Sale | 3,925 | 170.04 | 667,407 | D |
22 May 2024 17:14 | RGEN | REPLIGEN CORP | HUNT ANTHONY | Chief Executive Officer | 21 May 2024 | Sale | 2,963 | 169.27 | 501,547 | D |
22 May 2024 17:14 | RGEN | REPLIGEN CORP | HUNT ANTHONY | Chief Executive Officer | 21 May 2024 | Sale | 3,933 | 168.33 | 662,042 | D |
22 May 2024 17:14 | RGEN | REPLIGEN CORP | HUNT ANTHONY | Chief Executive Officer | 21 May 2024 | Sale | 4,008 | 167.05 | 669,536 | D |
22 May 2024 17:14 | RGEN | REPLIGEN CORP | HUNT ANTHONY | Chief Executive Officer | 21 May 2024 | Sale | 4,274 | 166.36 | 711,023 | D |
12 Mar 2024 20:24 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | 11 Mar 2024 | Sale | 3,517 | 193.73 | 681,348 | D |
11 Mar 2024 19:43 | RGEN | REPLIGEN CORP | HUNT ANTHONY | Chief Executive Officer | 08 Mar 2024 | Sale | 156 | 202.55 | 31,598 | D |
11 Mar 2024 19:43 | RGEN | REPLIGEN CORP | HUNT ANTHONY | Chief Executive Officer | 08 Mar 2024 | Sale | 806 | 201.75 | 162,610 | D |
11 Mar 2024 19:43 | RGEN | REPLIGEN CORP | HUNT ANTHONY | Chief Executive Officer | 08 Mar 2024 | Sale | 1,305 | 200.56 | 261,731 | D |
11 Mar 2024 19:43 | RGEN | REPLIGEN CORP | HUNT ANTHONY | Chief Executive Officer | 08 Mar 2024 | Sale | 1,822 | 199.53 | 363,544 | D |
11 Mar 2024 19:43 | RGEN | REPLIGEN CORP | HUNT ANTHONY | Chief Executive Officer | 08 Mar 2024 | Sale | 1,347 | 198.55 | 267,447 | D |
11 Mar 2024 19:43 | RGEN | REPLIGEN CORP | HUNT ANTHONY | Chief Executive Officer | 08 Mar 2024 | Sale | 1,666 | 197.39 | 328,852 | D |
11 Mar 2024 19:43 | RGEN | REPLIGEN CORP | HUNT ANTHONY | Chief Executive Officer | 08 Mar 2024 | Sale | 6,228 | 196.32 | 1,222,681 | D |
11 Mar 2024 19:43 | RGEN | REPLIGEN CORP | HUNT ANTHONY | Chief Executive Officer | 08 Mar 2024 | Sale | 3,377 | 195.49 | 660,170 | D |
28 Feb 2024 21:56 | RGEN | REPLIGEN CORP | DAWES KAREN A | Director | 27 Feb 2024 | Sale | 1,000 | 193.35 | 193,350 | D |
26 Feb 2024 20:38 | RGEN | REPLIGEN CORP | BYLUND JAMES | Chief Operating Officer | 23 Feb 2024 | Sale | 4,373 | 198.08 | 866,204 | D |
13 Nov 2023 17:10 | RGEN | REPLIGEN CORP | GEBSKI CHRISTINE | See Remarks | 10 Nov 2023 | Sale | 3,788 | 147.13 | 557,328 | D |
30 Aug 2023 16:06 | RGEN | REPLIGEN CORP | DAWES KAREN A | Director | 29 Aug 2023 | Sale | 850 | 171.38 | 145,673 | D |
08 May 2023 21:15 | RGEN | REPLIGEN CORP | MADAUS MARTIN D | Director | 08 May 2023 | Purchase | 500 | 156.18 | 78,090 | D |
08 May 2023 21:15 | RGEN | REPLIGEN CORP | MADAUS MARTIN D | Director | 05 May 2023 | Purchase | 500 | 159.19 | 79,595 | D |
08 May 2023 21:15 | RGEN | REPLIGEN CORP | MADAUS MARTIN D | Director | 04 May 2023 | Purchase | 500 | 161.15 | 80,575 | D |
17 Feb 2023 16:56 | RGEN | REPLIGEN CORP | SNODGRES JON | Chief Financial Officer | 16 Feb 2023 | Sale | 5,647 | 200 | 1,129,400 | D |
14 Nov 2022 17:43 | RGEN | REPLIGEN CORP | HUNT ANTHONY | Chief Executive Officer | 11 Nov 2022 | Sale | 25,000 | 200 | 5,000,000 | D |
09 Sep 2022 16:14 | RGEN | REPLIGEN CORP | DAWES KAREN A | Director | 09 Sep 2022 | Sale | 775 | 227.17 | 176,057 | D |
09 Sep 2022 16:14 | RGEN | REPLIGEN CORP | HUNT ANTHONY | Chief Executive Officer | 08 Sep 2022 | Sale | 245 | 227.01 | 55,617 | D |
09 Sep 2022 16:14 | RGEN | REPLIGEN CORP | HUNT ANTHONY | Chief Executive Officer | 08 Sep 2022 | Sale | 4,873 | 226.34 | 1,102,955 | D |
09 Sep 2022 16:14 | RGEN | REPLIGEN CORP | HUNT ANTHONY | Chief Executive Officer | 08 Sep 2022 | Sale | 10,490 | 225.22 | 2,362,558 | D |
09 Sep 2022 16:14 | RGEN | REPLIGEN CORP | HUNT ANTHONY | Chief Executive Officer | 08 Sep 2022 | Sale | 6,626 | 224.47 | 1,487,338 | D |
09 Sep 2022 16:14 | RGEN | REPLIGEN CORP | HUNT ANTHONY | Chief Executive Officer | 08 Sep 2022 | Sale | 1,389 | 223.26 | 310,108 | D |
09 Sep 2022 16:14 | RGEN | REPLIGEN CORP | HUNT ANTHONY | Chief Executive Officer | 08 Sep 2022 | Sale | 720 | 222.24 | 160,013 | D |
09 Sep 2022 16:14 | RGEN | REPLIGEN CORP | HUNT ANTHONY | Chief Executive Officer | 08 Sep 2022 | Sale | 1,235 | 221.46 | 273,503 | D |
09 Sep 2022 16:14 | RGEN | REPLIGEN CORP | HUNT ANTHONY | Chief Executive Officer | 08 Sep 2022 | Sale | 824 | 220.08 | 181,346 | D |
17 Aug 2022 16:41 | RGEN | REPLIGEN CORP | SNODGRES JON | Chief Financial Officer | 16 Aug 2022 | Sale | 2,400 | 253.16 | 607,584 | D |
17 Aug 2022 16:41 | RGEN | REPLIGEN CORP | SNODGRES JON | Chief Financial Officer | 16 Aug 2022 | Sale | 4,298 | 252.7 | 1,086,105 | D |
12 Aug 2022 16:49 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | 11 Aug 2022 | Sale | 4,040 | 254.14 | 1,026,726 | D |
12 Aug 2022 16:49 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | 11 Aug 2022 | Sale | 800 | 255.2 | 204,160 | D |
05 Aug 2022 16:29 | RGEN | REPLIGEN CORP | GEBSKI CHRISTINE | See Remarks | 04 Aug 2022 | Sale | 3,357 | 243.01 | 815,785 | D |
04 Aug 2022 16:32 | RGEN | REPLIGEN CORP | BYLUND JAMES | Chief Operating Officer | 03 Aug 2022 | Sale | 2,000 | 240.4 | 480,800 | D |
02 Aug 2022 17:26 | RGEN | REPLIGEN CORP | SNODGRES JON | Chief Financial Officer | 01 Aug 2022 | Sale | 2,000 | 220 | 440,000 | D |
22 Jul 2022 16:25 | RGEN | REPLIGEN CORP | HUNT ANTHONY | Chief Executive Officer | 21 Jul 2022 | Sale | 24,802 | 200 | 4,960,400 | D |
15 Dec 2022 06:55 | RGEN | REPLIGEN CORP | EGLINTON MANNER CARRIE | Director | 16 Mar 2022 | Purchase | 625 | 175.02 | 109,388 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)